Deficiencies in the publication and reporting of the results of systematic reviews presented at scientific medical conferences

被引:34
作者
Hopewell, Sally [1 ,2 ]
Boutron, Isabelle [1 ]
Altman, Douglas G. [2 ]
Ravaud, Philippe [1 ]
机构
[1] Univ Paris 05, Ctr Epidemiol Clin, INSERM U1153, Hop Hotel Dieu, F-75181 Paris, France
[2] Univ Oxford, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Ctr Stat Med, Botnar Res Ctr, Oxford OX3 7LD, England
关键词
Systematic reviews; Randomized controlled trials; Evidence-based health care; PRISMA statement; Abstracts; Critical appraisal; TRIAL ABSTRACTS; QUALITY; CONSORT; IMPACT; GUIDELINES; JOURNALS; NEEDS;
D O I
10.1016/j.jclinepi.2015.03.006
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Objectives: To evaluate the publication and quality of reporting of abstracts of systematic reviews presented at scientific medical conferences. Study Design and. Setting: We included all abstracts of systematic reviews published in the proceedings of nine leading international conferences in 2010. For each conference abstract, we searched PubMed (January 1, 2010, to June 2013) to identify their corresponding full publication. We assessed the extent to which conference abstracts and their corresponding journal abstract reported items included in the Preferred Reporting Items for Systematic reviews and Meta-Analysis for Abstracts checklist and recorded any important discrepancies between sources. Results: We identified 197 abstracts of systematic reviews, representing <1% of the total number of conference abstracts presented. Of these 53% were published in full, the median time to publication was 14 months (interquartile range, 6.6-20.1 months). Although most conference and journal abstracts reported details of included studies (conference n = 83 of 103; 81% vs. journal n = 81 of 103; 79%), size and direction of effect (76% vs. 75%), and conclusions (79% vs. 81%), many failed to report the date of search (27% vs. 25%), assessment of risk of bias (18% vs. 12%), and the result for the main efficacy outcome(s) including the number of studies (37% vs. 31%) and participants (30% vs. 20%), harms(s) (17% vs. 17%), strengths (17% vs. 13%) and limitations (36% vs. 30%) of the evidence, or funding source (1% vs. 0%). There were discrepancies between journal and corresponding conference abstracts including deletion of studies (13%), changes in reported efficacy (11%), and harm (10%) outcome(s) and changes in the nature or direction of conclusions (24%). Conclusion: Despite the importance of systematic reviews in the delivery of evidence-based health care, very few are presented at scientific conferences and only half of those presented are published in full. Serious deficiencies in the reporting of abstracts of systematic reviews make it difficult for readers to reliably assess their findings. (C) 2015 Elsevier Inc. All rights reserved.
引用
收藏
页码:1488 / 1495
页数:8
相关论文
共 21 条
  • [1] Seventy-Five Trials and Eleven Systematic Reviews a Day: How Will We Ever Keep Up?
    Bastian, Hilda
    Glasziou, Paul
    Chalmers, Iain
    [J]. PLOS MEDICINE, 2010, 7 (09):
  • [2] PRISMA for Abstracts: Reporting Systematic Reviews in Journal and Conference Abstracts
    Beller, Elaine M.
    Glasziou, Paul P.
    Altman, Douglas G.
    Hopewell, Sally
    Bastian, Hilda
    Chalmers, Iain
    Gotzsche, Peter C.
    Lasserson, Toby
    Tovey, David
    [J]. PLOS MEDICINE, 2013, 10 (04)
  • [3] Reporting of Effect Direction and Size in Abstracts of Systematic Reviews
    Beller, Elaine M.
    Glasziou, Paul P.
    Hopewell, Sally
    Altman, Douglas G.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2011, 306 (18): : 1981 - 1982
  • [4] The quality of reporting of trial abstracts is suboptimal: Survey of major general medical journals
    Berwanger, Otavio
    Ribeiro, Rodrigo A.
    Finkelsztejn, Alessandro
    Watanabe, Marcelo
    Suzumura, Erica A.
    Duncan, Bruce B.
    Devereaux, P. J.
    Cook, Deborah
    [J]. JOURNAL OF CLINICAL EPIDEMIOLOGY, 2009, 62 (04) : 387 - 392
  • [5] Empirical evidence for selective reporting of outcomes in randomized trials -: Comparison of Protocols to published articles
    Chan, AW
    Hróbjartsson, A
    Haahr, MT
    Gotzsche, PC
    Altman, DG
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 291 (20): : 2457 - 2465
  • [6] Reporting Quality of Abstracts Presented at the European Association of Urology Meeting: A Critical Assessment
    De Sio, Marco
    Yakoubi, Rachid
    De Nunzio, Cosimo
    Damiano, Rocco
    Balsamo, Raffaele
    Di Palma, Camine
    Cantiello, Francesco
    Azzarito, Giuseppina
    Mirone, Vicenzo
    Tubaro, Andrea
    Autorino, Riccardo
    [J]. JOURNAL OF UROLOGY, 2012, 188 (05) : 1883 - 1886
  • [7] Assessment of adherence to the CONSORT statement for quality of reports on randomized controlled trial abstracts from four high-impact general medical journals
    Ghimire, Saurav
    Kyung, Eunjung
    Kang, Wonku
    Kim, Eunyoung
    [J]. TRIALS, 2012, 13
  • [8] Reducing waste from incomplete or unusable reports of biomedical research
    Glasziou, Paul
    Altman, Douglas G.
    Bossuyt, Patrick
    Boutron, Isabelle
    Clarke, Mike
    Julious, Steven
    Michie, Susan
    Moher, David
    Wager, Elizabeth
    [J]. LANCET, 2014, 383 (9913) : 267 - 276
  • [9] USERS GUIDES TO THE MEDICAL LITERATURE .9. A METHOD FOR GRADING HEALTH-CARE RECOMMENDATIONS
    GUYATT, GH
    SACKETT, DL
    SINCLAIR, JC
    HAYWARD, R
    COOK, DJ
    COOK, RJ
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 274 (22): : 1800 - 1804
  • [10] CONSORT for reporting randomized controlled trials in journal and conference abstracts: Explanation and elaboration
    Hopewell, Sally
    Clarke, Mike
    Moher, David
    Wager, Elizabeth
    Middleton, Philippa
    Altman, Douglas G.
    Schulz, Kenneth F.
    [J]. PLOS MEDICINE, 2008, 5 (01) : 48 - 56